Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$6.23 USD
0.00 (0.00%)
Updated May 15, 2024 04:00 PM ET
After-Market: $6.32 +0.09 (1.44%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.68 | 3.39% |
Earnings Summary
For their last quarter, Verve Therapeutics (VERV) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.68 per share. This reflects a positive earnings surprise of 13.24%. Look out for VERV's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year increase of 21.84%.
Earnings History
Price & Consensus
Zacks News for VERV
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
VERV: What are Zacks experts saying now?
Zacks Private Portfolio Services